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Case Report
Development of EKC after Eximer Laser Photorefractive 
Surgery and Subsequent Recurrence of EKC-like Keratitis
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Department of Ophthalmology, Kim’s Eye Hospital, Myung-Gok Eye Research Institute, 
Konyang University College of Medicine, Seoul, Korea
This research focuses on four cases of patients having undergone eximer laser photorefractive surgery who were 
diagnosed with adenoviral keratoconjunctivitis during the postoperative period and who later developed epidemic 
keratoconjunctivitis (EKC)-like keratitis. Two of the patients had undergone laser-assisted subepithelial keratec-
tomy (LASEK), one had undergone laser in situ keratomileusis and one had photorefractive keratectomy. After the 
surgery adenoviral keratoconjunctivitis and recurrent late-developing EKC-like keratitis were observed in the 
patients. Recurrent late-developing EKC-like keratitis occurred in one of the patients, who had received LASEK as 
many as three times. The others had only one or two episodes.The corneal infiltrates of keratitis mainly occurred in 
the central cornea. Successful resolution of recurrent late-developing EKC-like keratitis was achieved through the 
use of topical steroids without sequelae and the final best-corrected visual acuity was as good as the base line. 
These keratitis infiltrates have been presumed to represent an immune response to the suspected adenoviral anti-
gens deposited in corneal stroma during the primary adenoviral infection. Previous reports argued that patients with 
a history of adenoviral ketatoconjunctivitis were succeptible to adenoviral keratoconjunctivitis becoming re-
activated; however, in our research, our patients had their first adenoviral infections after the eximer laser photo-
refractive surgery and reactivation was confirmed. We recommend that attention be paid to adenoviral infection af-
ter laser refractive operations, because these patients seem to have more frequent recurrences.
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Eximer laser photorefractive surgery is one of the most 
widely performed ophthalmic surgeries. Keratitis after such 
surgeries is a serious complication and is multifactorial in 
origin. Moreover, prior ocular herpes is a contraindication in 
the labeling of refractive surgery by the U.S. Food and Drug 
Administration (FDA) due to the reactivation of herpetic 
keratitis. Previous reports have shown the reactivation of 
presumed adenoviral keratitis after laser in situ keratomi-
leusis (LASIK), excimer laser keratectomy [1,2]. In this 
study, we report four cases of eximer laser photorefractive 
surgery which resulted in adenoviral keratoconjunctivitis in 
the postoperative period and then a late recurrence of epi-
demic keratoconjunctivitis (EKC)-like keratitis.
Case Report 1
In April 2007, a 35-year-old woman showed the symptom 
of decreased vision in both eyes. She had a clinical history of 
adenoviral keratoconjunctivitis in both eyes, diagnosed three 
weeks earlier, and photorefractive keratectomy (PRK) in 
both eyes, diagnosed in December 1999. During the initial 
visit, the uncorrected  visual  acuity was 20 / 40, the best-cor-
rected visual acuity (BCVA) was 20 / 20 in both eyes and the 
refraction was +1.50 +1.00 × 175 in the right eye and +0.50 
+1.25 × 25 in the left eye. Central subepithelial infiltrates in 
both eyes, some of which were on the previous infiltration 
sites, were seen during the slit lamp examination. There was 
no significant conjunctival hyperemia and in the anterior 
chamber reaction no abnormal findings were seen in the eye-
lid or conjunctivae. The tear break up time (TBUT) was 
within normal limits. Little areas of epithelium overlying the Korean J Ophthalmol Vol.25, No.6, 2011
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Fig. 1. Anterior segment photograhy showed multiple anterior stro-
mal opacification after epidemic keratoconjucntivitis in case 1.
Fig. 2. After treating a 3rd recurrence, the corneal opacities were 
milder, but still remained (case 1).
Fig. 3. Anterior segment photograhy showed some subepithelial in-
filtrations after epidemic keratoconjunctivitis in case 2.
Fig. 4. After the 3 months’ treatment with a topical steroid, only 
mild subepithelial opacifications were observed in case 2.
infiltrates were stained with a fluorescein solution. The pa-
tient had been treated with a 7-months taper of prednisolone 
acetate 0.1% in both eyes four times a day and, by the end of 
the treatment, the subepithelial infiltrates persisted only in a 
small region. 
Four months after, in March 2008, the patient reported in-
creased blurry vision in both eyes without conjunctival in-
jection, pain, or tearing. Her BCVA was 20 / 30 in the right 
eye, 20 / 40 in the left eye and her refraction was -0.50 +1.00
× 175 in the right eye and -1.00 +1.25 × 25 in the left eye. 
Both of her cornea exhibited some small central subepithelial 
infiltrates (Fig. 1). She was treated with a 5-months taper of 
prednisolone acetate 0.1% in both eyes. There was sig-
nificant improvement in her visual acuity. Her BCVA was 20 
/ 20 in the right eye and 20 / 25 in the left eye. Both central 
cornea had cleared, but some subepithelial opacity remained. 
On November 2008, two months after the last treatment, a 
subsequent third recrudescence of corneal inflammation oc-
curred in both eyes and required treatment with prednisolone 
acetate 0.1%, which was tapered over a 2-month period. The 
sites of reactivated infiltrates were similar to previous lesion 
sites, but not all of them were in the same locations. Her vi-
sion had improved to the baseline and her corneal in-
flammation resolved, leaving only minimal opacity (Fig. 2). 
After discharging the use of prednisolone acetate 0.1%, cy-
closporine A 0.05% (CsA, RestasisTM; Allergan Inc., Irvine, 
CA, USA) was started and further additional recurrence only 
recently occurred.
Case Report 2
A 30-year-old woman was diagnosed in December 2008, 
showing decreased vision in both eyes. She had a clinical his-
tory of adenoviral keratoconjunctivitis in both eyes, diag-
nosed two weeks prior, and laser-assisted subepithelial kera-
tectomy (LASEK) in both eyes diagnosed in August 2008. 
On the first visit, her BCVA was 20 / 40 in the right eye and 
20 / 20 in the left eye, -1.00 +0.75 × 180 in the right eye and SJ Park, et al. Recurrent Adenoviral Keratitis after Laser Surgery
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Table 1. Clinical courses
Operation name Operation date Adenoviral keratitis
Recurrence schedule (interval from first infection)
1st recurrence 2nd recurrence 3rd recurrence
Case 1 PRK 1999 Dec 2007 Mar 3 wk 12 mon 20 mon
Case 2 LASEK 2008 Aug 2008 Nov 2 wk
Case 3 LASEK 2007 Jan 2007 Jun 12 mon 16 mon
Case 4 LASIK 2006 Jan 2009 Apr 2 wk
PRK = photorefractive keratectomy; LASEK = laser-assisted subepithelial keratectomy; LASIK = laser in situ keratomileusis.
20 / 20, +0.25 in the left eye. Some central subepithelial in-
filtrates, moderate conjunctival hyperemia in the both eyes 
(Fig. 3) were observed during the slit lamp examination. The 
sites of reactivated infiltrates were similar to previous lesion 
sites, but not all of them were in the same locations. There 
were no abnormal findings in the eyelids or conjunctivae, 
with the TBUT within normal limits. Little areas of epi-
thelium overlying the infiltrates were stained with a fluo-
rescein solution. The patient was treated with a 3-month tap-
er of prednisolone acetate 0.1% in both eyes four times a day, 
resulting in subepithelial infiltrates persisting in only a small 
region. Her finalvision had improved to a BCVA of 20 / 20 in 
both eyes and the corneal inflammation resolved with mini-
mal opacity (Fig. 4).
Case Report 3
In June 2008, a 29-year-old woman showed symptom of 
decreased vision in her right eye. She had a clinical history of 
adenoviral keratoconjunctivitis in both eyes, diagnosed the 
previous year, and had LASEK in both eyes in January 2007, 
before adenoviral keratoconjunctivitis was found. In June 
2008, her BCVA was 20 / 50, -0.75 +0.50 × 135 in the right 
eye and 20 / 20, -0.75 +0.50 × 95 in the left eye. The slitlamp 
examination disclosed some central subepithelial infiltrates 
in the both eyes, but there was no significant conjunctival hy-
peremia or anterior chamber reaction and there were no ab-
normal findings on the eyelid or conjunctivae, with the 
TBUT within normal limits. Little areas of epithelium over-
lying the infiltrates were stained with a fluorescein solution. 
The patient was treated with a 3-month taper of prednisolone 
acetate 0.1% four times a day. The subepithelial infiltrates 
persisted in only a small region. On October 2008, a sub-
sequent second recrudescence of corneal inflammation oc-
curred in her right eye, with some of the infiltrates on the 
sites of previous infiltrates. The infiltrates required treatment 
with prednisolone acetate 0.1% that was tapered over a 
2-month period. Her vision improved and the EKC-like kera-
titis was resolved with minimal opacity. Finally, her vision 
improved to a BCVA of 20 / 20 in right eye.
Case Report 4
In May 2009, a 23-year-old woman was examined, show-
ing symptoms of decreased vision in her left eye. She had a 
clinical history of adenoviral keratoconjunctivitis in both 
eyes, diagnosed two weeks prior, and LASIK in both eyes, 
diagnosed in 2006. During the initial visit, her BCVA was 20 
/ 20 in her right eye and 20 / 30 in her left eye. Multiple sub-
epithelial infiltration was found in her central cornea of her 
left eye on the slitlamp exam., but there was no significant 
conjunctival hyperemia or anterior chamber reaction. 
Furthermore, there were no abnormal findings on her eyelid 
or conjunctivae, and her TBUT was within normal limits. 
Little areas of epithelium overlying the infiltrates were 
stained with fluorescein solution. The patient was treated 
with a 2-month taper of prednisolone acetate 0.1% in her left 
eye four times a day and the subepithelial infiltrates persisted 
in only a small region. Her final vision had improved to a 
BCVA of 20 / 20 in both eyes. After discharging the use of 
prednisolone acetate 0.1%, cyclosporine A 0.05% (CsA, 
RestasisTM) was started and there was no further recurrence.
Discussion
Summary of clinical courses of 4 cases  is  in  Table 1. Adenoviral 
keratoconjunctivitis is a common eye infection that can in-
duce subepithelial infiltrates, which can persist and recur. 
These infiltrates have been presumed to represent an immune 
response to suspected adenoviral antigens deposited in cor-
neal stroma during the primary adenoviral infection [3].
Post-LASIK keratitis is a serious complication. FDA label-
ing advises that previous herpes keratitis is a contraindication 
of laser surgery, but no further specific instructions have been 
provided for other forms of keratitis. Campos et al. [4] and 
Pineda and Talamo [5] reported cases of patients who had un-
dergone PRK and suffered from late-onset corneal haze fol-
lowing adenoviral keratoconjunctivitis, despite the fact that 
PRK was reported to eliminate central subepithelial corneal 
opacities and prevent recurrent keratitis within the treated 
area [6,7].
In previous reports on patients who had adenoviral ketato-
conjunctivitis prior to undergoing LASIK, PRK reported that 
adenoviral ketatoconjunctivitis was reactivated after the sur-
gery [1,2]. However, our patients had their first adenoviral 
infection episode after eximer laser photorefractive surgery 
and reactivation was confirmed. According to previous re-
ports, it was recommended that careful preoperative history 
taking and physical evaluation should be undergone to detect 
even a remote history of prior episodes of adenoviral kerati-Korean J Ophthalmol Vol.25, No.6, 2011
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tis, and ophthalmologists should explain the possible re-
activation of subepithelial infiltration to the patients [8]. In 
addition, we recommend paying attention to adenoviral in-
fection after laser refractive operations, because these pa-
tients seem to have more frequencies of recurrence than pa-
tients who did not have eximer laser photorefractive surgery. 
Patients should receive warnings about adenoviral infection 
after laser refractive surgery. 
Although no viral agent was isolated in our case, the clinical 
findings were consistent with previously reported adenoviral 
infections. The reactivation tendency of adenoviral keratitis 
was thought to be related to the eximer laser photorefractive 
surgery procedure; however, we found that the reactivation 
occurred when patients were under stressful conditions, such 
as physical fatigue and heavy drinking.
Recurrent adenoviral stromal keratitis is thought to represent 
a delayed hypersensitivity immune response to viral antigens 
in the corneal stroma [3]. The direct contact between epi-
thelial cells and corneal stroma can cause abnormal results 
for corneal wound healing after PRK [6,7]. Moreover, hyper-
active keratocytes or a loss of bowman’s layer [5] may have 
induced the unusual responses after adenoviral kerato-
conjunctivitis in our patients. Thus, the patients who under-
went eximer laser photorefractive surgery and did not have 
adenoviral keratitis before may have an increased possibility 
of reactivation of subepithelial infiltration , especially if they 
develop adenoviral keratoconjunctivitis after the surgery. 
Successful resolution of recurrent keratitis was achieved 
through the use of topical steroids without sequelae, both in 
our research and previous studies [1,2,8]. Withdrawal of top-
ical corticosteroid could be a cause of the recurrence of in-
flammation [9]. Also, adenoviral keratoconjunctivitis can be 
complicated by a recurrence of subepithelial infiltrates with 
no evidence of an inciting factor. In two of our cases re-
currence stopped after the use of cyclosporine A 0.05% (CsA, 
RestasisTM). Similar results were reported by Romanowski 
et al. [10], as topical cyclosporine A reduced adenoviral sub-
epithelial immune infiltrates by anti-inflammatory and anti-
immune effects, especially on T-cell activation.
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